Covered recipient · General Payments record
SPURTHI S SURPUR
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$2,314.12
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $624.99 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $264.84 | 14 |
| UCB, Inc. | $167.29 | 6 |
| ARGENX US, INC. | $49.84 | 2 |
| CSL Behring | $34.46 | 2 |
| Lundbeck LLC | $29.96 | 1 |
| Ipsen Biopharmaceuticals, Inc | $25.93 | 1 |
| Neurelis, Inc. | $23.57 | 1 |
| Lilly USA, LLC | $15.05 | 1 |
| Neurocrine BioSciences, Inc. | $14.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.94 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185559 | CMS |
| ABBVIE INC. | $25.03 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185561 | CMS |
| ABBVIE INC. | $24.31 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185563 | CMS |
| ABBVIE INC. | $14.44 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185565 | CMS |
| ABBVIE INC. | $10.39 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185567 | CMS |
| ABBVIE INC. | $32.79 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185569 | CMS |
| ABBVIE INC. | $8.51 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185571 | CMS |
| ABBVIE INC. | $9.44 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185573 | CMS |
| ABBVIE INC. | $34.07 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185575 | CMS |
| ABBVIE INC. | $27.06 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185577 | CMS |
| ABBVIE INC. | $6.95 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185579 | CMS |
| ABBVIE INC. | $8.86 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185581 | CMS |
| ABBVIE INC. | $20.16 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185583 | CMS |
| ABBVIE INC. | $23.89 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106185585 | CMS |
| ARGENX US, INC. | $19.86 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142103528 | CMS |
| ARGENX US, INC. | $29.98 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142110997 | CMS |
| CSL Behring | $18.70 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134614575 | CMS |
| CSL Behring | $15.76 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134614583 | CMS |
| Ipsen Biopharmaceuticals, Inc | $25.93 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091990143 | CMS |
| Lilly USA, LLC | $15.05 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135382637 | CMS |
| Lundbeck LLC | $29.96 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145973458 | CMS |
| Neurelis, Inc. | $23.57 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145656423 | CMS |
| Neurocrine Biosciences, Inc. | $14.05 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150877422 | CMS |
| UCB, Inc. | $30.04 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143193954 | CMS |
| UCB, Inc. | $29.76 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143193959 | CMS |
| UCB, Inc. | $26.91 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143193963 | CMS |
| UCB, Inc. | $28.40 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143193968 | CMS |
| UCB, Inc. | $31.63 | 07/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143193972 | CMS |
| UCB, Inc. | $20.55 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143193976 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.